Publication for HNRNPU and SYNCRIP

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	HNRNPU	heterogeneous nuclear ribonucleoprotein U	3192			[link]
hsa	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	10492

Pubmed ID	Priority	Text
29616096	0.98	HNRNPU and SYNCRIP were positively correlated with HOXA11-AS.
	0.97	heterogeneous nuclear ribonucleoprotein U (HNRNPU), high mobility group box 1 (HMGB1), phosphodiesterase 4D (PDE4D), synaptotagmin binding cytoplasmic RNA interacting protein (SYNCRIP), basic helix-loop-helix family member B9 (BHLHB9)] in NSCLC was analysed based on original data from TCGA database.
	0.97	HNRNPU, SYNCRIP and BHLHB9 were upregulated in lung adenocarcinoma and squamous cell carcinoma, whereas PDE4D was significantly downregulated in lung adenocarcinoma and squamous cell carcinoma (P<0.001).
	0.97	HNRNPU, heterogeneous nuclear ribonucleoprotein U; HMGB1, high mobility group box 1; PDE4D, phosphodiesterase 4D; SYNCRIP, synaptotagmin binding cytoplasmic RNA interacting protein; BHLHB9, basic helix-loop-helix family member B9.
	0.97	HNRNPU, HMGB1, PDE4D, SYNCRIP and BHLHB9 between lung squamous cell carcinoma and normal lung tissues based on the Cancer Genome Atlas database.
	0.95	HNRNPU, (C) HMGB1, (D) PDE4D, (E) SYNCRIP and (F) BHLHB9.
	0.94	HNRNPU, heterogeneous nuclear ribonucleoprotein U; HMGB1, high mobility group box 1; PDE4D, phosphodiesterase 4D; SYNCRIP, synaptotagmin binding cytoplasmic RNA interacting protein; BHLHB9, basic helix-loop-helix family member B9.
	0.89	HNRNPU, HMGB1, PDE4D, SYNCRIP, BHLHB9) were analysed.
	0.86	HNRNPU, HMGB1, PDE4D, SYNCRIP and BHLHB9) of miR-642b-3p were identified by all four prediction algorithms.
	0.73	HNRNPU, heterogeneous nuclear ribonucleoprotein U; HMGB1, high mobility group box 1; PDE4D, phosphodiesterase 4D; SYNCRIP, synaptotagmin binding cytoplasmic RNA interacting protein; BHLHB9, basic helix-loop-helix family member B9.
27507887	0.97	hnRNP U, IGF2BP2, YBX1, SYNCRIP and FUS remained bound to G5-Nter (Figure 2D, Supplementary Figure S3).
30872992	0.96	hnRNPU, SYNCRIP, RBMS3, Caprin-1 and NUPL2 (Bakkar et al.,).
	0.92	hnRNPU), Heterogeneous nuclear ribonucleoprotein Q (SYNCRIP), Putative RNA-binding protein 3 (RBMS3), ell Cycle Associated Protein 1 (Caprin-1) and Nucleoporin-like 2 (NUPL2).
25759500	0.96	hnRNP Q, hnRNP A1, hnRNP A0, hnRNP U, and p100.
28575276	0.96	hnRNP Q, hnRNP U, as well as the previously reported hnRNP K and PTBP1 (hnRNP I), preferentially bind to the wild-type A3B.
30302013	0.96	SYNCRIP, YMHAE, EEF1G, FLNA, HNRNPA2B1, PTBP1, ATP5A1, CCT3, RBMX, CCT8, ANXA2, CLTC, HNRNPU, LMNA, AHNAK, and FLNB (Fig. 3A).
19182532	0.90	hnRNP-U, Puralpha, Purbeta, PSF, DDX1, DDX3, SYNCRIP, TLS, NonO, HSPC117, ALY, CGI-99, Staufen, three FMRPs and EF-1alpha.
29134320	0.89	hnRNPU, Syncrip, RBMS3, Caprin-1 and NUPL2, showed significant alterations in ALS compared to controls.
	0.73	hnRNPU and Syncrip staining intensities.
28493890	0.56	SYNCRIP, SFRS9, SFRS6, SFRS2, NOVA1, KHSRP, HNRPA1, KHDRBS1, HNRPU, HNRPR, HNRPM, HNRPK, HNRPC, HNRPH1, HNRPF, and HNRPD).